Dear Valued Provider,
Effective December 12, 2016, generic Zetia (ezetimibe) became available in the market. Ezetimibe will remain Non-Formulary for Medicare Part D Covered Persons. Please see the attachment below for further processing instructions.


If you have any questions regarding claims processing, please contact the Prime Contact Center at 800.821.4795.

Sincerely,
Pharmacy Network Management
Prime Therapeutics LLC

Dear Valued Provider,
Effective January 1, 2017, Blue Cross Community Integrated Care Plan (ICP) and Blue Cross Community Family Health Plan (FHP) Covered Persons will be subject to a Morphine Equivalent Dose (MED) quantity limit. Please see the attachments below for further processing instructions.

If you have questions regarding claims processing, please call the Prime Contact Center at 800.821.4795.

Sincerely,
Pharmacy Network Management
Prime Therapeutics LLC

Prime Therapeutics Contracting Fax number: 877.823.6373

*Please see attached PDF for more information.

Members will be issued new pharmacy ID cards from MedImpact Healthcare Systems with their new member ID number. The new card will be active 01/01/17, so please request the new card information from the members starting 01/01/17.

*Please see attached PDF for more information.

We just want to remind you that Script Care will be adding two additional BINs effective January 1, 2017. Please see attached payer sheet for more information.